Roles of NAD in Protection of Axon against Degeneration via SIRT1 Pathways

Axonal degeneration is a common pathological change of neurogenical disease which often arises before the neuron death. But it had not found any effective method to protect axon from degeneration. In this study we intended to confirm the protective effect of nicotinamide adenine dinucleotide (NAD),...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of physiology Vol. 59; no. 2; p. 78
Main Authors Zhang, Jing, Guo, Wei-Hua, Qi, Xiao-Xia, Li, Gui-Bao, Hu, Yan-Lai, Wu, Qi, Ding, Zhao-Xi, Li, Hong-Yu, Hao, Jing, Sun, Jin-Hao
Format Journal Article
LanguageEnglish
Published India 30.04.2016
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Axonal degeneration is a common pathological change of neurogenical disease which often arises before the neuron death. But it had not found any effective method to protect axon from degeneration. In this study we intended to confirm the protective effect of nicotinamide adenine dinucleotide (NAD), investigate the optimal administration dosage and time of NAD, and identify the relationship between silence signal regulating factor 1 (SIRT1) and axonal degeneration. An axonal degeneration model was established using dorsal root ganglion (DRG) neurons injured by vincristine to observe the protective effects of NAD to the injured axons. In addition, the potential contribution of the SIRT1 in axonal degeneration was also investigated. Through the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, immunochemistry staining, axons counting and length measuring, transmission electron microscope (TEM) observation, we demonstrated that NAD played an important role in preventing axonal degeneration. Further study revealed that the expression of SIRT1 and phosphorylated Akt1 (p-Akt1) was up-regulated when NAD was added into the culturing medium. Taking together, our results demonstrated that NAD might delay the axonal degeneration through SIRT1/Akt1 pathways.
ISSN:0304-4920
DOI:10.4077/CJP.2016.BAD331